Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Taiho Pharmaceutical patents novel compounds for urinary incontinence

Dec. 16, 2014

Phase II data for sotatercept as treatment of anemia in hemodialysis subjects

Dec. 12, 2014

Researchers present phase III clinical data for ZS-9 as treatment of hyperkalemia

Dec. 2, 2014

Kissei Pharmaceutical discloses new TRPM8 antagonists

Nov. 24, 2014

Studies compare time to ESRD in aHUS patients treated with supportive care or eculizumab

Nov. 24, 2014

Kissei Pharmaceutical submits NDA in Japan for PA-21

Nov. 20, 2014

Daiichi Sankyo patents new phosphate transporter inhibitors

Nov. 12, 2014

PBI-4050 cleared to commence trials in patients with diabetic kidney disease

Nov. 12, 2014

Novel cystine derivatives inhibit stone formation in vivo

Nov. 7, 2014

Nymox's NX-1207 fails to achieve efficacy endpoints in phase III BPH trials

Nov. 3, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...